Cai, Xiurong
Yin, Guo
Chen, Shuai
Tacke, Frank
Guillot, Adrien
Liu, Hanyang
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 3 November 2023
Accepted: 30 April 2024
First Online: 20 June 2024
Declarations
:
: Animal experiments in this study were approved by the Animal Welfare Committee of the affiliated Changzhou Second People’s Hospital of Nanjing Medical University [Approval No. (2020) KYO 045 − 05].
: All authors have consented to the submission of this research paper.
: Frank Tacke’s lab has received research funding from Allergan, Bristol-Myers Squibb, Gilead and Inventiva. FT has received honoraria for consulting or lectures from Astra Zeneca, Gilead, AbbVie, BMS, Boehringer, Madrigal, Intercept, Falk, Ionis, Inventiva, Merz, Pfizer, Alnylam, NGM, CSL Behring, Novo Nordisk, Novartis.